Membership benefits

    • Participation in working groups to proactively shape future policies

      Working group for combined products, focusing amongst other things on:

      Medical Devices and In Vitro Diagnostics Regulations (MDR / IVDR) Regulations, and their upcoming implementing and delegated acts

      – Amendments to the Medicinal Product Directive EU 2001/83 affecting combined products, in particular Article 117 of Medical Device Regulation EU 2017/745 amending Medicinal Products Directive 2001/83/EC

      Regulatory challenges for combined products in terms of digital health, post market safety, vigilance notifications, EUDAMED, labelling etc

    • News alerts, intelligence on policy developments regarding combined products

    • Access to a platform with top level stakeholder interactions on innovative healthcare solutions

    • Access to scientific network and knowledge pool on combined products

    • Reduced fees for participation in MPP annual conference and MPP trainings